David Ege, PhD, is the Chief Technical Officer at ADC Therapeutics, where they focus on ensuring safe and high-quality manufacturing of antibody drug-conjugate therapies. With over 20 years of experience in the pharmaceutical and biotech industries, David specializes in manufacturing operations, QA/QC, and process development, contributing significantly to the approvals and launches of Keytruda, Gardasil, and VOWST. Previously, they held leadership positions at Merck and Seres Therapeutics, driving advancements in biologics and vaccine manufacturing. David earned a BSE in Chemical Engineering from Princeton University and a PhD in Chemical Engineering from the University of Pennsylvania.
This person is not in the org chart
This person is not in any teams
This person is not in any offices